Stocks to watch today: M&M, Tata Steel, Infosys, Bank, and others

As of 07:10 am, SGX Nifty April futures were bidding at 17,741 – indicating an early 40-point gain on the NSE Nifty 50. Major benchmark indices tracking marginally higher from overseas markets are likely to open positive signals. Meanwhile, investors’ eyes will be on D-Street reserve Bank of Indiamonetary policy results.

today’s earnings

Announcement of GTPL Hathway and PTC India Financial Services Q4 Results Today.

Stirling and Wilson Renewable Energy

The company reported a loss of Rs 126.61 crore for the quarter ended March 2022, lower than the loss of Rs 344.80 crore reported in the same period last year. However, the revenue fell sharply from Rs 1,364.5 crore to Rs 1,071 crore during the same period. In FY22, the loss stood at Rs 916 crore, up from Rs 290 crore in the previous year, while revenue rose marginally to Rs 5,199 crore from Rs 5,081 crore during the same period.

sonata software

The board has approved the appointment of Sameer Dhir as the CEO of the company with effect from April 8, 2022. Sreekar Reddy is voluntarily stepping down as CEO and will continue as Managing Director of the company.

Cholamandalam Investment and Finance Company

The company in a BSE filing said that the disbursements for Q4FY22 stood at around Rs 12,718 crore, an increase of 58 per cent as compared to the disbursements of Rs 8,071 crore in the corresponding period of the previous fiscal. Collection efficiency on billing improved across all product segments and stood at 138 per cent in Q4FY22 as against 120 per cent in the year-ago period.

Infosys

The IT company and Rolls-Royce enhanced strategic collaboration with the launch of a joint ‘Aerospace Engineering and Digital Innovation Centre’ in Bengaluru. The center will provide high-end research and development (R&D) services integrated with advanced digital capabilities for Rolls-Royce’s engineering and group business services from India.

Hester Biosciences

The company in its BSE filing said that the board has approved the execution of a Letter of Assistance Agreement by the Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise, for a grant of Rs 60 crore (in a phased manner) to the company. . , This mission will support COVID vaccine manufacturing under COVID Suraksha.

Grace

The company achieved total sales volume of 1.34 million sq ft of super built-up area and highest ever realization of Rs 1,109.6 crore for the quarter ended March 2022, while 1.33 million sq ft of super built-up area and Rs. 1,072 was recovered. crore in the year-ago period. Average realization per square foot in Q4FY22 was Rs 8,265 crore as against Rs 8,014 crore in Q4FY21.

Insurance

The insurance regulator, IRDA, wants to remove the minimum entry capital requirement of Rs 100 crore for setting up an insurance business to facilitate the entry of multiple players such as standalone micro insurers and niche players.

pharma

Indian pharmaceutical companies have been prolific with brand launches over the past 10 years, despite the decline in growth contribution from new products in recent years. Industry insiders say that brand launches are the lifeline of the pharma industry, and ensure steady volume growth and market share.

Disclaimer:Disclaimer: The views and investment tips of experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decision.

read all breaking news , today’s fresh news And IPL 2022 Live Updates Here.